Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease
6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3
CAS Number: 2070015-16-4
InChiKey: VJQALSOBHVEJQM-QAQDUYKDSA-N
PubMed PMID: 26738988
ITF2357 (Givinostat) ate (Monocaprin) A novel neurotrophic drug forGivinostat or gavinostat, aslo known as ITF2357, is a potent and orally active histone deacetylase inhibitor with potential anti inflammatory, anti angiogenic, and antineoplastic activities. It is a hydroxamate used in the form of its hydrochloride. Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis. ITF2357 reduces cytokines and protects islet cells in vivo and